caa a22 4500 477061540 CHVBK 20180405111402.0 cr unu---uuuuu 170330e19960301xx s 000 0 eng 10.1007/BF01061908 doi (NATIONALLICENCE)springer-10.1007/BF01061908 Dalen James College of Medicine, The University of Arizona, 85724, Tucson, AZ aut Highlights of the fourth ACCP Task Force on Antithrombotic Therapy [Elektronische Daten] [James Dalen] The Fourth ACCP Task Force on Antithrombotic Therapy met in Tucson, Arizona in March of 1995. These conferences began in 1985 because there were so many uncertainties at that time with regard to the indications, dosage, duration of therapy, and selection of antithrombotic agents for a wide variety of very common thromboembolic diseases. They have been held every 3 years since then. In our first publication in 1986, we had very few Grade A recommendations because there were very few Level 1 randomized clinical trials. At our Fourth Consensus Conference, held in 1995, we were able to evaluate a large number of Level 1 studies that allowed us to increase the number of Grade A recommendations. Kluwer Academic Publishers, 1996 atrial fibrillation nationallicence anticoagulant nationallicence stroke nationallicence cardioversion nationallicence heart valve nationallicence myocardial infarction nationallicence Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 2/4(1996-03-01), 261-264 0929-5305 2:4<261 1996 2 11239 https://doi.org/10.1007/BF01061908 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01061908 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Dalen James College of Medicine, The University of Arizona, 85724, Tucson, AZ aut NATIONALLICENCE 773 0- Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 2/4(1996-03-01), 261-264 0929-5305 2:4<261 1996 2 11239 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer